Pricing Log in Create free account

Bone Biologics Corp. (BBLG) vs Moolec Science SA (MLEC)

Bone Biologics Corp. and Moolec Science SA are both Biotechnology companies. Bone Biologics Corp. is the larger, with a market value of $1.1M against $620.0K — 1.8× the size. Bone Biologics Corp. has the higher net margin (0.00% vs −105.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Moolec Science SA leads on 6 and Bone Biologics Corp. on 5.

Valuation

Metric BBLG MLEC Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.03 9.40
P/B 0.20 0.01 2.13
Price to free cash flow n/m 0.01 25.18
EV/EBITDA n/m 1.76 0.66
EV/Sales n/m 8.37 9.02
Earnings yield (438.22%) (3,822.12%) (32.88%)
Free cash flow yield (214.89%) 8,301.70% (23.13%)

Profitability

Metric BBLG MLEC Biotechnology median
Gross margin — 2,373.25% 68.51%
Operating margin 0.00% 244.93% 0.00%
Net margin 0.00% (105.71%) 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (47.49%) 0.00% (51.96%)
Return on assets (44.46%) 0.00% (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BBLG MLEC Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 90.85% (793.17%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BBLG MLEC Biotechnology median
Debt to equity 0.00 4.37 0.00
Current ratio 13.38 0.15 4.97
Net debt to EBITDA 1.65 (2.73) 1.01

Dividend

Metric BBLG MLEC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BBLG MLEC Biotechnology median
Market cap 1.10m 620.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack